Table 2 |
|||
|
Clinical changes after a switch from etanercept to infliximab |
|||
|
Parameter |
Pre-infliximab (baseline) |
Post-infliximab (4 doses; week 14) |
Outcome |
|
|
|||
|
Mean tender joints (n) |
17.1 |
7.3 |
57% reduction |
|
Mean swollen joints (n) |
11.2 |
3.8 |
66% reduction |
|
ESR (mm/h) |
33 |
26.5 |
20% reduction |
|
Mean prednisone dosage (mg/day) |
9.2 |
5.7 |
38% reduction |
|
|
|||
|
ESR, erythrocyte sedimentation rate. Data from [17]. |
|||
|
Yocum Arthritis Res Ther 2004 6(Suppl 2):S24 doi:10.1186/ar997 |
|||